144 related articles for article (PubMed ID: 8212290)
21. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of thyroxine on cytokine production by T cells in mice.
Yao C; Zhang J; Wang L; Guo Y; Tian Z
Int Immunopharmacol; 2007 Dec; 7(13):1747-54. PubMed ID: 17996685
[TBL] [Abstract][Full Text] [Related]
23. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
24. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
[No Abstract] [Full Text] [Related]
25. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
[TBL] [Abstract][Full Text] [Related]
26. [Expression of non-T cell derived cytokines in acute rejection after heart transplantation: experiment with mouse model].
Liang TB; Yu ZY; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):26-30. PubMed ID: 16606531
[TBL] [Abstract][Full Text] [Related]
27. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
[TBL] [Abstract][Full Text] [Related]
28. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
29. Tolerance after portal venous immunization is enhanced by anti-IFN-gamma and is maintained only with persistence of antigen.
Gorczynski RM; Chen Z
Transplant Proc; 1995 Feb; 27(1):227-9. PubMed ID: 7878979
[No Abstract] [Full Text] [Related]
30. Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
Spriewald BM; Billing JS; Ensminger SM; Morris PJ; Wood KJ
Cytokine; 2002 Jul; 19(1):6-13. PubMed ID: 12200107
[TBL] [Abstract][Full Text] [Related]
31. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
32. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells.
Xu DL; Liu Y; Tan JM; Li B; Zhong CP; Zhang XH; Wu CQ; Tang XD
Scand J Immunol; 2004 Jun; 59(6):536-44. PubMed ID: 15182248
[TBL] [Abstract][Full Text] [Related]
33. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
Mottram PL; Pietersz GA; Purcell LJ; Krauer K; McKenzie IF
Transplant Proc; 1992 Oct; 24(5):2301. PubMed ID: 1413068
[No Abstract] [Full Text] [Related]
35. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
[No Abstract] [Full Text] [Related]
36. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
37. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
[TBL] [Abstract][Full Text] [Related]
38. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
39. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.
Hamano K; Rawsthorne M; Bushell A; Morris PJ; Wood KJ
Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951
[No Abstract] [Full Text] [Related]
40. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
